From ‘lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline
Indian Journal of Physiology and Pharmacology · 11.07.2026 · 1-2
DOI: 10.25259/ijpp_10_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Physiology and Pharmacology, online erschienen am 11.07.2026. Verfasst von Mulavagili Vijayasimha und 1 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vijayasimha, M., & Srikanth, M. (2026). From ‘lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline. Indian Journal of Physiology and Pharmacology, 0, 1-2. https://doi.org/10.25259/ijpp_10_2026
Vancouver
Vijayasimha M, Srikanth M. From ‘lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline. Indian Journal of Physiology and Pharmacology. 2026;0:1-2. doi:10.25259/ijpp_10_2026
BibTeX
@article{Vijayasimha2026,
author = {Vijayasimha, Mulavagili and Srikanth, M.},
title = {From ‘lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline},
journal = {Indian Journal of Physiology and Pharmacology},
year = {2026},
volume = {0},
pages = {1--2},
doi = {10.25259/ijpp_10_2026}
}
EUVIMED